Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine

Targeting of NMDA receptors in new treatments for schizophrenia

(2014) Kenji Hashimoto   EXPERT OPINION ON THERAPEUTIC TARGETS

Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain

(2014) Kenji Hashimoto   SCHIZOPHRENIA RESEARCH

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

(2013) Silvia Sacchi et al.   CURRENT PHARMACEUTICAL DESIGN

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

(2013) Kenji Hashimoto et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders

(2013) Arundhati Jana et al.   Journal of Neuroimmune Pharmacology

Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine

(2013) Qian Ren et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine

(2013) Qian Ren et al.   PSYCHOPHARMACOLOGY

Inflammation and Schizophrenia

(2013) B. Kirkpatrick et al.   SCHIZOPHRENIA BULLETIN

A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia

(2013) Marina Ermilov et al.   SCHIZOPHRENIA RESEARCH

Add-on Treatment of Benzoate for Schizophrenia

(2013) Hsien-Yuan Lane et al.   JAMA Psychiatry

A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia

(2012) Mark Weiser et al.   JOURNAL OF CLINICAL PSYCHIATRY

Plasma levels of D-serine in Brazilian individuals with schizophrenia

(2012) Marilia A. Calcia et al.   SCHIZOPHRENIA RESEARCH

Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration

(2012) Yumi Shirai et al.   Clinical Psychopharmacology and Neuroscience

Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia

(2011) Dana V. Ferraris et al.   CURRENT PHARMACEUTICAL DESIGN

Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons

(2011) Saurabh Khasnavis et al.   Journal of Neuroimmune Pharmacology

Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice

(2011) Mao Horio et al.   NEUROCHEMISTRY INTERNATIONAL

Contributions of the d-serine pathway to schizophrenia

(2011) Viviane Labrie et al.   NEUROPHARMACOLOGY

Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine

(2011) Hongxian Chen et al.   PSYCHOPHARMACOLOGY

Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia

(2010) Daisuke Matsuzawa et al.   ANTIOXIDANTS & REDOX SIGNALING

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

(2010) Jeffrey K. Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

(2010) Guochuan Tsai et al.   CURRENT PHARMACEUTICAL DESIGN

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine

(2009) Kenji Hashimoto et al.   BIOLOGICAL PSYCHIATRY

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors

(2009) Yuko Tanibuchi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses

(2009) S. Brahmachari et al.   JOURNAL OF IMMUNOLOGY

Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’

(2009) Kenji Hashimoto   JOURNAL OF PSYCHOPHARMACOLOGY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors

(2008) Hiroko Hagiwara et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors

(2008) Dana Ferraris et al.   JOURNAL OF MEDICINAL CHEMISTRY

Microglial activation in schizophrenia and minocycline treatment

(2008) Kenji Hashimoto   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

(2008) Caroline Madeira et al.   SCHIZOPHRENIA RESEARCH

Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711

(2007) Kenji Hashimoto et al.   BIOLOGICAL PSYCHIATRY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine

(2007) Kenji Hashimoto et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

(2007) Yuko Fujita et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY